Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_16522:p2
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 16522 (pt 2/2)
Character Range: 990955–992397

medication prior to pregnancy;
                     (ii) cardiac disease (co‑managed with a specialist physician and with echocardiographic evidence of myocardial dysfunction);
                     (iii) previous renal or liver transplant;
                     (iv) renal dialysis;
                     (v) chronic liver disease with documented oesophageal varices;
                     (vi) renal insufficiency in early pregnancy (serum creatinine greater than 110 mmol/L);
                     (vii) neurological disorder that confines the patient to a wheelchair throughout pregnancy;
                     (viii) maternal height of less than 148 cm;
                     (ix) a body mass index greater than or equal to 40;
                     (x) pre‑existing diabetes mellitus on medication prior to pregnancy;
                     (xi) thyrotoxicosis requiring medication;
                     (xii) previous thrombosis or thromboembolism requiring anticoagulant therapy through pregnancy and the early puerperium;
                     (xiii) thrombocytopenia with platelet count of less than 100,000 prior to 20 weeks gestation;
                     (xiv) HIV, hepatitis B or hepatitis C carrier status positive;
                     (xv) red cell or platelet iso‑immunisation;
                     (xvi) cancer with metastatic disease;
                     (xvii) illicit drug misuse during pregnancy
                     (H) (Anaes.)